000 01648 a2200457 4500
005 20250512212220.0
264 0 _c19841205
008 198412s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM198411223112106
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCooper, D S
245 0 0 _aAntithyroid drugs.
_h[electronic resource]
260 _bThe New England journal of medicine
_cNov 1984
300 _a1353-62 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAdult
650 0 4 _aAgranulocytosis
_xchemically induced
650 0 4 _aAutoimmune Diseases
_xchemically induced
650 0 4 _aChemical and Drug Induced Liver Injury
_xetiology
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aFetus
_xdrug effects
650 0 4 _aGraves Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHyperthyroidism
_xdrug therapy
650 0 4 _aImmunity
_xdrug effects
650 0 4 _aImmunoglobulins
_xanalysis
650 0 4 _aInfant, Newborn
650 0 4 _aInsulin Antibodies
650 0 4 _aLeukopenia
_xchemically induced
650 0 4 _aLupus Vulgaris
_xchemically induced
650 0 4 _aMethimazole
_xadministration & dosage
650 0 4 _aMilk, Human
_xanalysis
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
_xdrug therapy
650 0 4 _aPropylthiouracil
_xadministration & dosage
650 0 4 _aVascular Diseases
_xchemically induced
773 0 _tThe New England journal of medicine
_gvol. 311
_gno. 21
_gp. 1353-62
856 4 0 _uhttps://doi.org/10.1056/NEJM198411223112106
_zAvailable from publisher's website
999 _c6387387
_d6387387